Progressive Care Inc. Reports Strong February Sales and Leads Efforts to Combat Novel Coronavirus Infections - Seite 2

Florida House Bill 389- Authorization of Florida pharmacists to test and treat certain diseases

The new law signed by Gov. Ron Desantis will enable pharmacists to treat certain diseases while under contract with a physician. The company has been working on its Tele-medicine endeavor for the expressed purpose of enhancing access and quality of care in the community. The new law will further benefit this project.

PrEP Program

The Company’s pharmacies were approved to be included in a program created by Gilead to donate 200,000 bottles of PrEP medication a year for the next 10 years. Beginning April 1st, Progressive Care’s current network of doctors and pharmacists will be able to provide PrEP treatment services to Florida communities. The campaign to lower infection rates in Florida will be supported by outreach efforts to physicians as well as digital assets to encourage patient engagement with services.

“We have always been at the forefront of combating infectious diseases in our communities. We stand ready to do our part to support healthcare officials, physicians, and patients during this time of crisis,” said S. Parikh Mars. “We are taking all necessary precautions to ensure we are able to mobilize at a large scale without interruption.”

Connect and stay in touch with us on social media:

Progressive Care Inc.

https://www.facebook.com/ProgressiveCareUS/

https://twitter.com/ProgressCareUS

PharmCo Rx

https://www.facebook.com/pharmcorx/

https://twitter.com/PharmCoRx

Five Star RX

https://www.fivestarrx.com/

https://www.facebook.com/fivestarrx/

About Progressive Care Inc.

Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida technology and health services organization that provides prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward-Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

CONTACT: Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
[e-mail]
www.progressivecareus.com
www.pharmcorx.com

Public Relations Contact:
Carlos Rangel
[e-mail]